Between The Lines

Nirsevimab for Prevention of RSV in Healthy Late-Preterm and Term Infants

August 31st 2023

Experts discuss the recently FDA-approved nirsevimab for the prevention of Respiratory Syncytial Virus (RSV) for late-preterm and term infants, highlighting a recent study on the safety and efficacy of nirsevimab.

Improved Glycemic Control Using a Bluetooth®-Connected Blood Glucose Meter and a Mobile Diabetes App: Real-World Evidence From Over 144,000 People With Diabetes

May 19th 2023

Experts in diabetes care review data relating to real-world evidence of the use of The OneTouch Reveal mobile app with the OneTouch Verio Flex® blood glucose (BG) meter to optimize and improve glycemic metrics in patients with type 1 and 2 diabetes.

Real World Evidence and Clinical Utility of KidneyIntelX on Patients With Early-Stage Diabetic Kidney Disease

April 26th 2023

Expert primary care physicians discuss a study on the use of the KidneyIntelX test in patients with diabetic kidney disease (DKD). They discuss the practical and clinical implications of the risk assessment capabilities of the test to improve screening and health outcomes for patients at risk for progressive kidney failure related to DKD.

Between The Lines: Role of Bempedoic Acid in Clinical Practice

August 4th 2021

Harold E. Bays, MD, and Steven E. Nissen, MD, examine the safety and efficacy data presented within the review article “Role of Bempedoic Acid in Clinical Practice”, and highlight clinical implications.